Aeterna Zentaris Announces Replacement At the Market Issuance Program

Aeterna Zentaris Announces Replacement At the Market Issuance Program


Wainwright will act as sales agent for any sales made under the new ATM program. The Common Shares will be sold at market prices prevailing at the time of the sale of the Common Shares, and, as a result, prices may vary.



from Biotech News